Does UPADACITINIB Cause Deep vein thrombosis? 206 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 206 reports of Deep vein thrombosis have been filed in association with UPADACITINIB (Rinvoq). This represents 0.3% of all adverse event reports for UPADACITINIB.
206
Reports of Deep vein thrombosis with UPADACITINIB
0.3%
of all UPADACITINIB reports
4
Deaths
84
Hospitalizations
How Dangerous Is Deep vein thrombosis From UPADACITINIB?
Of the 206 reports, 4 (1.9%) resulted in death, 84 (40.8%) required hospitalization, and 15 (7.3%) were considered life-threatening.
Is Deep vein thrombosis Listed in the Official Label?
Yes, Deep vein thrombosis is listed as a known adverse reaction in the official FDA drug label for UPADACITINIB.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Deep vein thrombosis?
LENALIDOMIDE (3,286)
RIVAROXABAN (3,180)
TESTOSTERONE (2,213)
APIXABAN (1,944)
ETHINYL ESTRADIOL\ETONOGESTREL (1,577)
RITUXIMAB (1,287)
METHOTREXATE (1,146)
DROSPIRENONE\ETHINYL ESTRADIOL (1,139)
DEXAMETHASONE (1,067)
ADALIMUMAB (1,056)
Which UPADACITINIB Alternatives Have Lower Deep vein thrombosis Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL